AXIM Looks to Help Chemotherapy Effects via CBD Chewing Gum with Dronabinol

- Ad -
  • AXIM’s contract manufacturer will be developing the new gum.
  • Rather than using THC or CBD, the formula includes a synthetic version of THC called dronabinol.

One of the consistent reasons for the use of medical marijuana has been in conjunction with a cancer diagnosis or cancer treatment, like chemotherapy. Chemotherapy can make patients lose their appetite, often from the nausea associated with their medication. While medical marijuana may not be the easiest method of use for some patients, AXIM Biotechnologies is using the substance for a new product that targets exactly this audience – a chewing gum.

According to reports from Market Exclusive, the chewing gum is being developed with dronabinol, which is a synthetic version of THC. AXIM’s contract manufacturer Eurofins Amatsigroup in Belgium is taking over the manufacturing of the new product, which will go through clinical studies with AXIM as a remedy for chemotherapy-related symptoms. Some of the symptoms of chemotherapy include a weakened immune system, pain, nausea, vomiting, and diarrhea.

Chemotherapy is prescribed to nearly 650,000 cancer patients every year, according to data from the Center for Disease Control and Prevention, costing about $100,000 per patient every year.

AXIM already has made plans for a bioequivalence study, examining the use of both their new chewing gum and FDA-approved capsules, which both contain dronabinol, in the next few months. Later, the company will be showing their evidence that the use of this dronabinol gum could be used as an alternative to the dronabinol that is orally ingested to soothe chemotherapy patients.

The CEO of AXIM, John Huemoeller II, commented that the use of the chewing gum to deliver the substance makes it easier to

“enter the body through the oral mucosa, bypassing the liver and allowing for greater bioavailability.” He added that, in the upcoming studies, the company’s goal is to “show the bioequivalence of our dronabinol gum to already FDA-approved synthetic THC products so that we can offer it to chemotherapy patients.”

Market Exclusive first broke news of this development, and we will be sure to keep you updated with more information once available.

Mike Roet

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.


Recent Posts

  • Top Brands

Fam Organics CBD: USDA Certified Organic CBD Oils and Topicals

Two months after its debut in May, Fam Organics has managed to cement its reputation…

20 hours ago
  • Tinctures & Drops

Herbal Grown CBD Oil: Safe Full Spectrum Hemp Oil Tincture?

People suffering from chronic pain, stress, insomnia, and anxiety can stop using chemically formulated remedies…

1 day ago
  • Tinctures & Drops

Bloomfield CBD: Is Bloomfield Hills Organic Full Spectrum Oil Legit?

CBD, one of hemp’s ingredients that carries the most therapeutic benefits, and the Bloomfield Hills…

1 day ago
  • Announcements

The Next Marijuana Millionaire Show Debuts Trailer with BigMike

Michael “BigMike” Straumietis, the famous self-made entrepreneur who revolutionized the entire cannabis industry with Advanced…

2 days ago
  • Announcements

New B GREAT Trade Up Offer Debuts with Full-Size CBD Oil Exchange Program

B GREAT recently announced a Tincture Trade-up Program. The renowned CBD brand, which is committed…

2 days ago
  • Announcements

FARMACEUTICALRX Launches Burst of Wellness Medical Marijuana Brand

The multistate therapeutics and medical marijuana company FARMACEUTICALRX has just announced that it’s going to…

2 days ago